
Early treatment with COVID-19 survivors’ blood plasma doesn’t prevent disease progression in people who have mild COVID-19 symptoms but are at risk for more severe illness, a new clinical trial finds. “As physicians, we wanted this to make a big difference in reducing severe illness and it did not,” said principal investigator Dr. Clifton Callaway,… read on > read on >